These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 32432841)

  • 1. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Albitar HA; Olitsky SE; Clancy MS; Iyer VN
    Haemophilia; 2020 Nov; 26(6):1038-1045. PubMed ID: 32432841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.
    Buscarini E; Botella LM; Geisthoff U; Kjeldsen AD; Mager HJ; Pagella F; Suppressa P; Zarrabeitia R; Dupuis-Girod S; Shovlin CL;
    Orphanet J Rare Dis; 2019 Feb; 14(1):28. PubMed ID: 30717761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians.
    Al-Samkari H
    Semin Thromb Hemost; 2022 Jul; 48(5):514-528. PubMed ID: 35226946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
    Dupuis-Girod S; Shovlin CL; Kjeldsen AD; Mager HJ; Sabba C; Droege F; Fargeton AE; Fialla AD; Gandolfi S; Hermann R; Lenato GM; Manfredi G; Post MC; Rennie C; Suppressa P; Sure U; ; Buscarini E
    Eur J Med Genet; 2022 Oct; 65(10):104575. PubMed ID: 35940549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemorrhagic telangiectasia (OslerWeberRendu syndrome) - Part II. Pharmacological therapy and international guidelines for the therapy 2020.
    Adam Z; Brančiková D; Romanová G; Pour L; Krejčí M; König J; Nebeský T; Adamová Z; Štork M; Krejčí M; Ševčíková S; Eid M; Sandecká V; Král Z
    Vnitr Lek; 2021; 67(7):419-424. PubMed ID: 35459360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known?
    Morrissey E; Schmidt-Martin D; Buckley M
    Eur J Case Rep Intern Med; 2024; 11(1):004219. PubMed ID: 38223286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of effectiveness of coblation for recurrent epistaxis in hereditary hemorrhagic telangiectasia.
    Feller CN; Adams JA; Friedland DR; Poetker DM
    Am J Otolaryngol; 2022; 43(3):103409. PubMed ID: 35216850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
    Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
    Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aflibercept for Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia: A Case Report.
    Villanueva B; Iriarte A; Torres-Iglesias R; Muñoz Bolaño M; Cerdà P; Riera-Mestre A
    Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of bevacizumab on familial epistaxis caused by hereditary hemorrhagic telangiectasia].
    Zhang J; Wang XS; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 56(5):436-441. PubMed ID: 34010995
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
    Dupuis-Girod S; Rivière S; Lavigne C; Fargeton AE; Gilbert-Dussardier B; Grobost V; Leguy-Seguin V; Maillard H; Mohamed S; Decullier E; Roux A; Bernard L; Saurin JC; Saroul N; Faure F; Cartier C; Altwegg R; Laccourreye L; Oberti F; Beaudoin M; Dhelens C; Desvignes C; Azzopardi N; Paintaud G; Hermann R; Chinet T
    J Intern Med; 2023 Dec; 294(6):761-774. PubMed ID: 37592715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osler's disease - a disease with a wide variety of clinical manifestations deserving multidisciplinary competence].
    Rönnblom A; Ellingsen J; Frykholm C; Karlsson T; Larsson B; Nelander M; Rorsman F; Thor A; Lidian A
    Lakartidningen; 2022 Aug; 119():. PubMed ID: 36082917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.
    Galiatsatos P; Wilson C; O'Brien J; Gong AJ; Angiolillo D; Johnson J; Myers C; Strout S; Mathai S; Robinson G; Rowan NR; Weiss CR
    Orphanet J Rare Dis; 2022 Jun; 17(1):220. PubMed ID: 35698080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review.
    Zhang E; Virk ZM; Rodriguez-Lopez J; Al-Samkari H
    Thromb Res; 2023 Jun; 226():150-155. PubMed ID: 37163869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.
    Pagella F; Pusateri A; Maiorano E; Spinozzi G; Ugolini S; Lizzio R; Mirabella R; Tinelli C; Olivieri C; Matti E
    Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):59-68. PubMed ID: 33746224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia.
    Virk ZM; Zhang E; Rodriguez-Lopez J; Witkin A; Wong AK; Luther J; Lin AE; Ning M; Grabowski E; Holbrook EH; Al-Samkari H
    J Thromb Haemost; 2023 Jan; 21(1):26-36. PubMed ID: 36695393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
    Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I Treat Bleeding in Hereditary Hemorrhagic Telangiectasia.
    Al-Samkari H
    Blood; 2024 Jun; ():. PubMed ID: 38864625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia.
    Wang D; Ito S; Waldron C; Butt A; Zhang E; Krumholz HM; Al-Samkari H; Goshua G
    Blood Adv; 2024 Jun; 8(11):2835-2845. PubMed ID: 38537061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Gutiérrez-Macías A; Barroso-Benayos I; Burzako-Sánchez A
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):433-434. PubMed ID: 37833139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.